A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis
Condition(s):Relapsing Multiple SclerosisLast Updated:December 15, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Relapsing Multiple SclerosisLast Updated:December 15, 2022Withdrawn
Condition(s):Relapsing Multiple SclerosisLast Updated:October 1, 2021Completed
Condition(s):Relapsing Multiple SclerosisLast Updated:April 29, 2022Completed
Condition(s):Relapsing Multiple Sclerosis (RMS)Last Updated:March 25, 2024Active, not recruiting
Condition(s):Relapsing Multiple Sclerosis (RMS)Last Updated:October 3, 2023Active, not recruiting
Condition(s):Relapsing Multiple SclerosisLast Updated:May 24, 2016Terminated
Condition(s):Relapsing Multiple Sclerosis; Multiple SclerosisLast Updated:March 27, 2024Withdrawn
Condition(s):Relapsing Multiple SclerosisLast Updated:June 1, 2023Withdrawn
Condition(s):Multiple SclerosisLast Updated:January 4, 2023Completed
Condition(s):Autoimmune Diseases; Relapsing Multiple SclerosisLast Updated:December 2, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.